These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35752205)

  • 101. Neurocysticercosis infection and disease-A review.
    Gripper LB; Welburn SC
    Acta Trop; 2017 Feb; 166():218-224. PubMed ID: 27880878
    [TBL] [Abstract][Full Text] [Related]  

  • 102. In vitro effects of albendazole sulfoxide and praziquantel against Taenia solium and Taenia crassiceps cysts.
    Palomares F; Palencia G; Pérez R; González-Esquivel D; Castro N; Cook HJ
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2302-4. PubMed ID: 15155240
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts.
    Mahanty S; Paredes A; Marzal M; Gonzalez E; Rodriguez S; Dorny P; Guerra-Giraldez C; Garcia HH; Nash T
    Antimicrob Agents Chemother; 2011 Jan; 55(1):211-7. PubMed ID: 21041508
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Neurocysticercosis in a Japanese woman with lung cancer who repeatedly visited endemic countries.
    Kinouchi T; Morishima Y; Uyama S; Miyamoto T; Horiguchi H; Fujimoto N; Ueta H
    BMC Infect Dis; 2021 Oct; 21(1):1077. PubMed ID: 34663259
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Combined Albendazole and Praziquantel Therapy in an Adult Female with Neurocysticercosis and Generalized Tonic-clonic Seizures.
    Petrov K; Ihongbe F; Chang M; Choudhary S; Bhatia D
    Cureus; 2018 Jul; 10(7):e2996. PubMed ID: 30245950
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Demographics and Clinical Characteristics of Patients with Neurocysticercosis: A Retrospective Study from Dali, China.
    Zhu HX; Li YC; Yang XP; Chu YH; Guo W; Chen RX; Guo DD; Cheng LJ; Li Y
    Saudi J Med Med Sci; 2023; 11(4):283-291. PubMed ID: 37970452
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Efficacy and safety of praziquantel in the treatment of neurocysticercosis in Vietnam.
    Thang TD; Phuc TQ; Thanh DT; Thieu NQ; Tho TH; Loi CB; Tran-Anh L
    Trop Biomed; 2022 Sep; 39(3):462-466. PubMed ID: 36214445
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The efficacy of the benzimidazoles oxfendazole and flubendazole against
    Risch F; Scheunemann JF; Reichwald JJ; Lenz B; Ehrens A; Gal J; Fercoq F; Koschel M; Fendler M; Hoerauf A; Martin C; Hübner MP
    Front Microbiol; 2023; 14():1213143. PubMed ID: 37440891
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Standardizing an Experimental Murine Model of Extraparenchymal Neurocysticercosis That Immunologically Resembles Human Infection.
    Espinosa-Cerón A; Méndez A; Hernández-Aceves J; Juárez-González JC; Villalobos N; Hernández M; Díaz G; Soto P; Concha L; Pérez-Osorio IN; Ortiz-Retana JJ; Bobes RJ; Parkhouse RM; Hamamoto Filho PT; Fragoso G; Sciutto E
    Brain Sci; 2023 Jul; 13(7):. PubMed ID: 37508953
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Effect of Hydroxyurea on Morphology, Proliferation, and Protein Expression on
    Rios-Valencia DG; Estrada K; Calderón-Gallegos A; Tirado-Mendoza R; Bobes RJ; Laclette JP; Cabrera-Bravo M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892261
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Natural history of extraparenchymal neurocysticercosis.
    Murrieta I; Flores X; Osorio R; Kuschick Feher J; Carrillo-Mezo R; Fleury A
    Trans R Soc Trop Med Hyg; 2021 Oct; 115(10):1218-1225. PubMed ID: 33587139
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Vertigo: An Atypical Presentation of Neurocysticercosis Successfully Treated With Albendazole.
    Mesa E; Ruprecht V; Nguyen MC; Casadesus D
    Cureus; 2023 Sep; 15(9):e45722. PubMed ID: 37868522
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Variation of the 2D Pattern of Brain Proteins in Mice Infected with
    Díaz-Zaragoza M; Hernández-Ávila R; Landa A; Ostoa-Saloma P
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338740
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Oxidative Stress in the Murine Model of Extraparenchymal Neurocysticercosis.
    Generoso D; Martins TC; Camacho CRC; Segredo MPF; Batah SS; Fabro AT; Sciutto E; Fleury A; Hamamoto Filho PT; Zanini MA
    Microorganisms; 2024 Sep; 12(9):. PubMed ID: 39338534
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci.
    Lima NF; Picanço GA; Alves DSMM; Silva LD; Isac E; Costa TL; Lino Junior RS; Vinaud MC
    Acta Trop; 2019 Feb; 190():361-364. PubMed ID: 30553893
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Oxfendazole Nitazoxanide combination in experimental neurocysticercosis - Anti-inflammatory and cysticidal effects.
    Araújo JAA; Gomes TC; Lima VCN; Silva YBD; Lino Junior RS; Vinaud MC
    Exp Parasitol; 2024 Jul; 262():108764. PubMed ID: 38677580
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Partial inhibition of the main energetic pathways and its metabolic consequences after
    Picanço GA; de Lima NF; Gomes TC; Fraga CM; Alves DSMM; Castillo R; da Costa TL; Lino-Junior RS; Ambrosio J; Vinaud MC
    Parasitology; 2019 Oct; 146(12):1578-1582. PubMed ID: 31303189
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Current approaches to cysticidal drug therapy for neurocysticercosis.
    Del Brutto OH
    Expert Rev Anti Infect Ther; 2020 Aug; 18(8):789-798. PubMed ID: 32331507
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Oxfendazole induces protein catabolism and gluconeogenesis in experimental neurocysticercosis.
    Correia LTB; de Lima NF; Gomes TC; De Sousa Guerra CH; Costa TL; Vinaud MC
    Acta Trop; 2022 Oct; 234():106571. PubMed ID: 35752205
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.